Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial

R. Hetzel, Gerd; Schmitz, Martina; Wissing, H.; Ries, W; Schott, G; Heering, Peter; Isgro, Frank; Kribben, Andreas; Himmele, Rainer; Grabensee, B.; C. Rump, L.

doi:10.1093/ndt/gfq575

Public

Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial

Published in Nephrology Dialysis Transplantation • Sep 27, 2010

Authors:

Gerd R. Hetzel

Martina Schmitz

H. Wissing

Abstract

BACKGROUND: Continuous venovenous haemofiltration (CVVH) in the intensive care setting requires anticoagulation to prevent clotting of the extracorporeal circuit. Several protocols avoiding heparin and using regional citrate anticoagulation have been developed to diminish bleeding risks. However, da...

Subject

Medicine

Heparin

Critically ill

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!